APO Research
Talk to an analyst

APO RESEARCH · REPORT

Labeled Nucleotides

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Labeled Nucleotides Industry Growth and Trends Forecast to 2032

22 December 2025108 pages

Choose your research edition.

Industry ResearchLabeled Nucleotides Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Labeled Nucleotides Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Labeled Nucleotides Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Labeled Nucleotides Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Labeled Nucleotides Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Labeled Nucleotides market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Labeled Nucleotides is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Labeled Nucleotides is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Labeled Nucleotides is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Labeled Nucleotides include ThermoFisher Scientific, Nanjing BioTogether, F. Hoffmann-La Roche, Yumpu, Star Lake Bioscience, Promega Corporation, Meihua Group, Lallemand and Jena Bioscience, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Labeled Nucleotides market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Labeled Nucleotides market size, estimates, and forecasts are presented in terms of sales volume (k tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Labeled Nucleotides market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Labeled Nucleotides.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Labeled Nucleotides market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Labeled Nucleotides Market by Company

ThermoFisher Scientific

Nanjing BioTogether

F. Hoffmann-La Roche

Yumpu

Star Lake Bioscience

Promega Corporation

Meihua Group

Lallemand

Jena Bioscience

DSM Nutritional Products

CJ CheilJedang Corporation

Biorigin

Agilent Technologies

Affymetrix

Labeled Nucleotides Segment by Type

Gene Chips & Microarrays

SNP by Pyrosequencing

TaqMan Allelic Discrimination

Labeled Nucleotides Segment by Application

Hospital Laboratories

Academic Research Laboratories

Reference Laboratories

Other Laboratories

Labeled Nucleotides Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Labeled Nucleotides market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Labeled Nucleotides and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Labeled Nucleotides.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Labeled Nucleotides manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Labeled Nucleotides in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Gene Chips & Microarrays Table 2. Major Company of SNP by Pyrosequencing Table 3. Major Company of TaqMan Allelic Discrimination Table 4. Global Labeled Nucleotides Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Labeled Nucleotides Sales by Type (2021-2026) & (k tons) Table 6. Global Labeled Nucleotides Sales Market Share in Volume by Type (2021-2026) Table 7. Global Labeled Nucleotides Sales by Type (2021-2026) & (US$ Million) Table 8. Global Labeled Nucleotides Sales Market Share in Value by Type (2021-2026) Table 9. Global Labeled Nucleotides Price by Type (2021-2026) & (US$/ton) Table 10. Global Labeled Nucleotides Sales by Type (2027-2032) & (k tons) Table 11. Global Labeled Nucleotides Sales Market Share in Volume by Type (2027-2032) Table 12. Global Labeled Nucleotides Sales by Type (2027-2032) & (US$ Million) Table 13. Global Labeled Nucleotides Sales Market Share in Value by Type (2027-2032) Table 14. Global Labeled Nucleotides Price by Type (2027-2032) & (US$/ton) Table 15. North America Labeled Nucleotides Sales by Type (2021-2026) & (k tons) Table 16. North America Labeled Nucleotides Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Labeled Nucleotides Sales by Type (2021-2026) & (k tons) Table 18. Europe Labeled Nucleotides Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Labeled Nucleotides Sales by Type (2021-2026) & (k tons) Table 20. Asia-Pacific Labeled Nucleotides Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Labeled Nucleotides Sales by Type (2021-2026) & (k tons) Table 22. Latin America Labeled Nucleotides Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Labeled Nucleotides Sales by Type (2021-2026) & (k tons) Table 24. Middle East and Africa Labeled Nucleotides Sales by Type (2021-2026) & (US$ Million) Table 25. Labeled Nucleotides Industry Trends Table 26. Labeled Nucleotides Industry Drivers Table 27. Labeled Nucleotides Industry Opportunities and Challenges Table 28. Labeled Nucleotides Industry Restraints Table 29. Global Labeled Nucleotides Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Labeled Nucleotides Revenue Market Share by Company (2021-2026) Table 31. Global Labeled Nucleotides Sales by Company (2021-2026) & (k tons) Table 32. Global Labeled Nucleotides Sales Share by Company (2021-2026) Table 33. Global Labeled Nucleotides Market Price by Company (2021-2026) & (US$/ton) Table 34. Global Labeled Nucleotides Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Labeled Nucleotides Major Company Production Sites and Headquarters Table 36. Global Labeled Nucleotides Company, Product Type & Application Table 37. Global Labeled Nucleotides Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Labeled Nucleotides by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Labeled Nucleotides Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Labeled Nucleotides Sales by Region (2021-2026) & (k tons) Table 42. Global Labeled Nucleotides Sales Market Share in Volume by Region (2021-2026) Table 43. Global Labeled Nucleotides Sales by Region (2021-2026) & (US$ Million) Table 44. Global Labeled Nucleotides Sales Market Share in Value by Region (2021-2026) Table 45. Global Labeled Nucleotides Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 46. Global Labeled Nucleotides Sales by Region (2027-2032) & (k tons) Table 47. Global Labeled Nucleotides Sales Market Share in Volume by Region (2027-2032) Table 48. Global Labeled Nucleotides Sales by Region (2027-2032) & (US$ Million) Table 49. Global Labeled Nucleotides Sales Market Share in Value by Region (2027-2032) Table 50. Global Labeled Nucleotides Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2027-2032) Table 51. Global Labeled Nucleotides Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Labeled Nucleotides Sales by Application (2021-2026) & (k tons) Table 53. Global Labeled Nucleotides Sales Market Share in Volume by Application (2021-2026) Table 54. Global Labeled Nucleotides Sales by Application (2021-2026) & (US$ Million) Table 55. Global Labeled Nucleotides Sales Market Share in Value by Application (2021-2026) Table 56. Global Labeled Nucleotides Price by Application (2021-2026) & (US$/ton) Table 57. Global Labeled Nucleotides Sales by Application (2027-2032) & (k tons) Table 58. Global Labeled Nucleotides Sales Market Share in Volume by Application (2027-2032) Table 59. Global Labeled Nucleotides Sales by Application (2027-2032) & (US$ Million) Table 60. Global Labeled Nucleotides Sales Market Share in Value by Application (2027-2032) Table 61. Global Labeled Nucleotides Price by Application (2027-2032) & (US$/ton) Table 62. North America Labeled Nucleotides Sales by Application (2021-2026) & (k tons) Table 63. North America Labeled Nucleotides Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Labeled Nucleotides Sales by Application (2021-2026) & (k tons) Table 65. Europe Labeled Nucleotides Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Labeled Nucleotides Sales by Application (2021-2026) & (k tons) Table 67. Asia-Pacific Labeled Nucleotides Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Labeled Nucleotides Sales by Application (2021-2026) & (k tons) Table 69. Latin America Labeled Nucleotides Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Labeled Nucleotides Sales by Application (2021-2026) & (k tons) Table 71. Middle East and Africa Labeled Nucleotides Sales by Application (2021-2026) & (US$ Million) Table 72. ThermoFisher Scientific Company Information Table 73. ThermoFisher Scientific Business Overview Table 74. ThermoFisher Scientific Labeled Nucleotides Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 75. ThermoFisher Scientific Labeled Nucleotides Product Portfolio Table 76. ThermoFisher Scientific Recent Development Table 77. Nanjing BioTogether Company Information Table 78. Nanjing BioTogether Business Overview Table 79. Nanjing BioTogether Labeled Nucleotides Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 80. Nanjing BioTogether Labeled Nucleotides Product Portfolio Table 81. Nanjing BioTogether Recent Development Table 82. F. Hoffmann-La Roche Company Information Table 83. F. Hoffmann-La Roche Business Overview Table 84. F. Hoffmann-La Roche Labeled Nucleotides Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 85. F. Hoffmann-La Roche Labeled Nucleotides Product Portfolio Table 86. F. Hoffmann-La Roche Recent Development Table 87. Yumpu Company Information Table 88. Yumpu Business Overview Table 89. Yumpu Labeled Nucleotides Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 90. Yumpu Labeled Nucleotides Product Portfolio Table 91. Yumpu Recent Development Table 92. Star Lake Bioscience Company Information Table 93. Star Lake Bioscience Business Overview Table 94. Star Lake Bioscience Labeled Nucleotides Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 95. Star Lake Bioscience Labeled Nucleotides Product Portfolio Table 96. Star Lake Bioscience Recent Development Table 97. Promega Corporation Company Information Table 98. Promega Corporation Business Overview Table 99. Promega Corporation Labeled Nucleotides Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 100. Promega Corporation Labeled Nucleotides Product Portfolio Table 101. Promega Corporation Recent Development Table 102. Meihua Group Company Information Table 103. Meihua Group Business Overview Table 104. Meihua Group Labeled Nucleotides Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 105. Meihua Group Labeled Nucleotides Product Portfolio Table 106. Meihua Group Recent Development Table 107. Lallemand Company Information Table 108. Lallemand Business Overview Table 109. Lallemand Labeled Nucleotides Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 110. Lallemand Labeled Nucleotides Product Portfolio Table 111. Lallemand Recent Development Table 112. Jena Bioscience Company Information Table 113. Jena Bioscience Business Overview Table 114. Jena Bioscience Labeled Nucleotides Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 115. Jena Bioscience Labeled Nucleotides Product Portfolio Table 116. Jena Bioscience Recent Development Table 117. DSM Nutritional Products Company Information Table 118. DSM Nutritional Products Business Overview Table 119. DSM Nutritional Products Labeled Nucleotides Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 120. DSM Nutritional Products Labeled Nucleotides Product Portfolio Table 121. DSM Nutritional Products Recent Development Table 122. CJ CheilJedang Corporation Company Information Table 123. CJ CheilJedang Corporation Business Overview Table 124. CJ CheilJedang Corporation Labeled Nucleotides Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 125. CJ CheilJedang Corporation Labeled Nucleotides Product Portfolio Table 126. CJ CheilJedang Corporation Recent Development Table 127. Biorigin Company Information Table 128. Biorigin Business Overview Table 129. Biorigin Labeled Nucleotides Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 130. Biorigin Labeled Nucleotides Product Portfolio Table 131. Biorigin Recent Development Table 132. Agilent Technologies Company Information Table 133. Agilent Technologies Business Overview Table 134. Agilent Technologies Labeled Nucleotides Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 135. Agilent Technologies Labeled Nucleotides Product Portfolio Table 136. Agilent Technologies Recent Development Table 137. Affymetrix Company Information Table 138. Affymetrix Business Overview Table 139. Affymetrix Labeled Nucleotides Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 140. Affymetrix Labeled Nucleotides Product Portfolio Table 141. Affymetrix Recent Development Table 142. North America Labeled Nucleotides Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 143. North America Labeled Nucleotides Sales by Country (2021-2026) & (k tons) Table 144. North America Labeled Nucleotides Sales Market Share by Country (2021-2026) Table 145. North America Labeled Nucleotides Sales Forecast by Country (2027-2032) & (k tons) Table 146. North America Labeled Nucleotides Sales Market Share Forecast by Country (2027-2032) Table 147. North America Labeled Nucleotides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. North America Labeled Nucleotides Market Size by Country (2021-2026) & (US$ Million) Table 149. North America Labeled Nucleotides Market Share by Country (2021-2026) Table 150. North America Labeled Nucleotides Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. North America Labeled Nucleotides Market Share Forecast by Country (2027-2032) Table 152. Europe Labeled Nucleotides Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 153. Europe Labeled Nucleotides Sales by Country (2021-2026) & (k tons) Table 154. Europe Labeled Nucleotides Sales Market Share by Country (2021-2026) Table 155. Europe Labeled Nucleotides Sales Forecast by Country (2027-2032) & (k tons) Table 156. Europe Labeled Nucleotides Sales Market Share Forecast by Country (2027-2032) Table 157. Europe Labeled Nucleotides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Europe Labeled Nucleotides Market Size by Country (2021-2026) & (US$ Million) Table 159. Europe Labeled Nucleotides Market Share by Country (2021-2026) Table 160. Europe Labeled Nucleotides Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Europe Labeled Nucleotides Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Labeled Nucleotides Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Labeled Nucleotides Sales by Country (2021-2026) & (k tons) Table 164. Asia-Pacific Labeled Nucleotides Sales Market Share by Country (2021-2026) Table 165. Asia-Pacific Labeled Nucleotides Sales Forecast by Country (2027-2032) & (k tons) Table 166. Asia-Pacific Labeled Nucleotides Sales Market Share Forecast by Country (2027-2032) Table 167. Asia-Pacific Labeled Nucleotides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Asia-Pacific Labeled Nucleotides Market Size by Country (2021-2026) & (US$ Million) Table 169. Asia-Pacific Labeled Nucleotides Market Share by Country (2021-2026) Table 170. Asia-Pacific Labeled Nucleotides Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Asia-Pacific Labeled Nucleotides Market Share Forecast by Country (2027-2032) Table 172. Latin America Labeled Nucleotides Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 173. Latin America Labeled Nucleotides Sales by Country (2021-2026) & (k tons) Table 174. Latin America Labeled Nucleotides Sales Market Share by Country (2021-2026) Table 175. Latin America Labeled Nucleotides Sales Forecast by Country (2027-2032) & (k tons) Table 176. Latin America Labeled Nucleotides Sales Market Share Forecast by Country (2027-2032) Table 177. Latin America Labeled Nucleotides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Latin America Labeled Nucleotides Market Size by Country (2021-2026) & (US$ Million) Table 179. Latin America Labeled Nucleotides Market Share by Country (2021-2026) Table 180. Latin America Labeled Nucleotides Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Latin America Labeled Nucleotides Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Labeled Nucleotides Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Labeled Nucleotides Sales by Country (2021-2026) & (k tons) Table 184. Middle East and Africa Labeled Nucleotides Sales Market Share by Country (2021-2026) Table 185. Middle East and Africa Labeled Nucleotides Sales Forecast by Country (2027-2032) & (k tons) Table 186. Middle East and Africa Labeled Nucleotides Sales Market Share Forecast by Country (2027-2032) Table 187. Middle East and Africa Labeled Nucleotides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 188. Middle East and Africa Labeled Nucleotides Market Size by Country (2021-2026) & (US$ Million) Table 189. Middle East and Africa Labeled Nucleotides Market Share by Country (2021-2026) Table 190. Middle East and Africa Labeled Nucleotides Market Size Forecast by Country (2027-2032) & (US$ Million) Table 191. Middle East and Africa Labeled Nucleotides Market Share Forecast by Country (2027-2032) Table 192. Key Raw Materials Table 193. Raw Materials Key Suppliers Table 194. Labeled Nucleotides Distributors List Table 195. Labeled Nucleotides Customers List Table 196. Research Programs/Design for This Report Table 197. Authors List of This Report Table 198. Secondary Sources Table 199. Primary Sources List of Figures Figure 1. Labeled Nucleotides Image Figure 2. Global Labeled Nucleotides Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Labeled Nucleotides Market Size (2021-2032) & (US$ Million) Figure 4. Global Labeled Nucleotides Sales (2021-2032) & (k tons) Figure 5. Gene Chips & Microarrays Image Figure 6. Global Gene Chips & Microarrays Sales YoY Growth (2021-2032) & (k tons) Figure 7. SNP by Pyrosequencing Image Figure 8. Global SNP by Pyrosequencing Sales YoY Growth (2021-2032) & (k tons) Figure 9. TaqMan Allelic Discrimination Image Figure 10. Global TaqMan Allelic Discrimination Sales YoY Growth (2021-2032) & (k tons) Figure 11. Global Labeled Nucleotides Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Labeled Nucleotides Market Share by Type 2025 VS 2032 Figure 13. North America Labeled Nucleotides Sales Market Share in Volume by Type in 2025 Figure 14. North America Labeled Nucleotides Sales Market Share in Value by Type in 2025 Figure 15. Europe Labeled Nucleotides Sales Market Share in Volume by Type in 2025 Figure 16. Europe Labeled Nucleotides Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Labeled Nucleotides Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Labeled Nucleotides Sales Market Share in Value by Type in 2025 Figure 19. Latin America Labeled Nucleotides Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Labeled Nucleotides Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Labeled Nucleotides Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Labeled Nucleotides Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Labeled Nucleotides Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Laboratories Image Figure 26. Global Hospital Laboratories Sales YoY Growth (2021-2032) & (k tons) Figure 27. Academic Research Laboratories Image Figure 28. Global Academic Research Laboratories Sales YoY Growth (2021-2032) & (k tons) Figure 29. Reference Laboratories Image Figure 30. Global Reference Laboratories Sales YoY Growth (2021-2032) & (k tons) Figure 31. Other Laboratories Image Figure 32. Global Other Laboratories Sales YoY Growth (2021-2032) & (k tons) Figure 33. Global Labeled Nucleotides Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Labeled Nucleotides Market Share by Application 2025 VS 2032 Figure 35. North America Labeled Nucleotides Sales Market Share in Volume by Application in 2025 Figure 36. North America Labeled Nucleotides Sales Market Share in Value by Application in 2025 Figure 37. Europe Labeled Nucleotides Sales Market Share in Volume by Application in 2025 Figure 38. Europe Labeled Nucleotides Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Labeled Nucleotides Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Labeled Nucleotides Sales Market Share in Value by Application in 2025 Figure 41. Latin America Labeled Nucleotides Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Labeled Nucleotides Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Labeled Nucleotides Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Labeled Nucleotides Sales Market Share in Value by Application in 2025 Figure 45. North America Labeled Nucleotides Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 46. North America Labeled Nucleotides Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Labeled Nucleotides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Labeled Nucleotides Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Labeled Nucleotides Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 50. Europe Labeled Nucleotides Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Labeled Nucleotides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Labeled Nucleotides Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Labeled Nucleotides Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 54. Asia-Pacific Labeled Nucleotides Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Labeled Nucleotides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Labeled Nucleotides Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Labeled Nucleotides Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 58. Latin America Labeled Nucleotides Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Labeled Nucleotides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Labeled Nucleotides Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Labeled Nucleotides Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 62. Middle East and Africa Labeled Nucleotides Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Labeled Nucleotides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Labeled Nucleotides Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Labeled Nucleotides Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Labeled Nucleotides Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Gene Chips & Microarrays
  • SNP by Pyrosequencing
  • TaqMan Allelic Discrimination
Applications
  • Hospital Laboratories
  • Academic Research Laboratories
  • Reference Laboratories
  • Other Laboratories
Companies covered
  • ThermoFisher Scientific
  • Nanjing BioTogether
  • F. Hoffmann-La Roche
  • Yumpu
  • Star Lake Bioscience
  • Promega Corporation
  • Meihua Group
  • Lallemand
  • Jena Bioscience
  • DSM Nutritional Products
  • CJ CheilJedang Corporation
  • Biorigin
  • Agilent Technologies
  • Affymetrix

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Labeled Nucleotides Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Labeled Nucleotides Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Labeled Nucleotides Market by Type
  6. 1.3.1 Gene Chips & Microarrays
  7. 1.3.2 SNP by Pyrosequencing
  8. 1.3.3 TaqMan Allelic Discrimination
  9. 1.4 Global Labeled Nucleotides Market Size by Type
  10. 1.4.1 Global Labeled Nucleotides Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Labeled Nucleotides Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Labeled Nucleotides Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Labeled Nucleotides Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Labeled Nucleotides Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Labeled Nucleotides Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Labeled Nucleotides Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Labeled Nucleotides Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Labeled Nucleotides Industry Trends
  2. 2.2 Labeled Nucleotides Industry Drivers
  3. 2.3 Labeled Nucleotides Industry Opportunities and Challenges
  4. 2.4 Labeled Nucleotides Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Labeled Nucleotides Revenue (2021-2026)
  2. 3.2 Global Top Players by Labeled Nucleotides Sales (2021-2026)
  3. 3.3 Global Top Players by Labeled Nucleotides Price (2021-2026)
  4. 3.4 Global Labeled Nucleotides Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Labeled Nucleotides Major Company Production Sites & Headquarters
  6. 3.6 Global Labeled Nucleotides Company, Product Type & Application
  7. 3.7 Global Labeled Nucleotides Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Labeled Nucleotides Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Labeled Nucleotides Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Labeled Nucleotides Tier 1, Tier 2, and Tier 3
4 Labeled Nucleotides Regional Status and Outlook
  1. 4.1 Global Labeled Nucleotides Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Labeled Nucleotides Historic Market Size by Region
  3. 4.2.1 Global Labeled Nucleotides Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Labeled Nucleotides Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Labeled Nucleotides Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Labeled Nucleotides Forecasted Market Size by Region
  7. 4.3.1 Global Labeled Nucleotides Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Labeled Nucleotides Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Labeled Nucleotides Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Labeled Nucleotides by Application
  1. 5.1 Labeled Nucleotides Market by Application
  2. 5.1.1 Hospital Laboratories
  3. 5.1.2 Academic Research Laboratories
  4. 5.1.3 Reference Laboratories
  5. 5.1.4 Other Laboratories
  6. 5.2 Global Labeled Nucleotides Market Size by Application
  7. 5.2.1 Global Labeled Nucleotides Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Labeled Nucleotides Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Labeled Nucleotides Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Labeled Nucleotides Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Labeled Nucleotides Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Labeled Nucleotides Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Labeled Nucleotides Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Labeled Nucleotides Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 ThermoFisher Scientific
  2. 6.1.1 ThermoFisher Scientific Company Information
  3. 6.1.2 ThermoFisher Scientific Business Overview
  4. 6.1.3 ThermoFisher Scientific Labeled Nucleotides Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 ThermoFisher Scientific Labeled Nucleotides Product Portfolio
  6. 6.1.5 ThermoFisher Scientific Recent Developments
  7. 6.2 Nanjing BioTogether
  8. 6.2.1 Nanjing BioTogether Company Information
  9. 6.2.2 Nanjing BioTogether Business Overview
  10. 6.2.3 Nanjing BioTogether Labeled Nucleotides Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Nanjing BioTogether Labeled Nucleotides Product Portfolio
  12. 6.2.5 Nanjing BioTogether Recent Developments
  13. 6.3 F. Hoffmann-La Roche
  14. 6.3.1 F. Hoffmann-La Roche Company Information
  15. 6.3.2 F. Hoffmann-La Roche Business Overview
  16. 6.3.3 F. Hoffmann-La Roche Labeled Nucleotides Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 F. Hoffmann-La Roche Labeled Nucleotides Product Portfolio
  18. 6.3.5 F. Hoffmann-La Roche Recent Developments
  19. 6.4 Yumpu
  20. 6.4.1 Yumpu Company Information
  21. 6.4.2 Yumpu Business Overview
  22. 6.4.3 Yumpu Labeled Nucleotides Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Yumpu Labeled Nucleotides Product Portfolio
  24. 6.4.5 Yumpu Recent Developments
  25. 6.5 Star Lake Bioscience
  26. 6.5.1 Star Lake Bioscience Company Information
  27. 6.5.2 Star Lake Bioscience Business Overview
  28. 6.5.3 Star Lake Bioscience Labeled Nucleotides Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Star Lake Bioscience Labeled Nucleotides Product Portfolio
  30. 6.5.5 Star Lake Bioscience Recent Developments
  31. 6.6 Promega Corporation
  32. 6.6.1 Promega Corporation Company Information
  33. 6.6.2 Promega Corporation Business Overview
  34. 6.6.3 Promega Corporation Labeled Nucleotides Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Promega Corporation Labeled Nucleotides Product Portfolio
  36. 6.6.5 Promega Corporation Recent Developments
  37. 6.7 Meihua Group
  38. 6.7.1 Meihua Group Company Information
  39. 6.7.2 Meihua Group Business Overview
  40. 6.7.3 Meihua Group Labeled Nucleotides Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Meihua Group Labeled Nucleotides Product Portfolio
  42. 6.7.5 Meihua Group Recent Developments
  43. 6.8 Lallemand
  44. 6.8.1 Lallemand Company Information
  45. 6.8.2 Lallemand Business Overview
  46. 6.8.3 Lallemand Labeled Nucleotides Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Lallemand Labeled Nucleotides Product Portfolio
  48. 6.8.5 Lallemand Recent Developments
  49. 6.9 Jena Bioscience
  50. 6.9.1 Jena Bioscience Company Information
  51. 6.9.2 Jena Bioscience Business Overview
  52. 6.9.3 Jena Bioscience Labeled Nucleotides Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Jena Bioscience Labeled Nucleotides Product Portfolio
  54. 6.9.5 Jena Bioscience Recent Developments
  55. 6.10 DSM Nutritional Products
  56. 6.10.1 DSM Nutritional Products Company Information
  57. 6.10.2 DSM Nutritional Products Business Overview
  58. 6.10.3 DSM Nutritional Products Labeled Nucleotides Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 DSM Nutritional Products Labeled Nucleotides Product Portfolio
  60. 6.10.5 DSM Nutritional Products Recent Developments
  61. 6.11 CJ CheilJedang Corporation
  62. 6.11.1 CJ CheilJedang Corporation Company Information
  63. 6.11.2 CJ CheilJedang Corporation Business Overview
  64. 6.11.3 CJ CheilJedang Corporation Labeled Nucleotides Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 CJ CheilJedang Corporation Labeled Nucleotides Product Portfolio
  66. 6.11.5 CJ CheilJedang Corporation Recent Developments
  67. 6.12 Biorigin
  68. 6.12.1 Biorigin Company Information
  69. 6.12.2 Biorigin Business Overview
  70. 6.12.3 Biorigin Labeled Nucleotides Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Biorigin Labeled Nucleotides Product Portfolio
  72. 6.12.5 Biorigin Recent Developments
  73. 6.13 Agilent Technologies
  74. 6.13.1 Agilent Technologies Company Information
  75. 6.13.2 Agilent Technologies Business Overview
  76. 6.13.3 Agilent Technologies Labeled Nucleotides Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Agilent Technologies Labeled Nucleotides Product Portfolio
  78. 6.13.5 Agilent Technologies Recent Developments
  79. 6.14 Affymetrix
  80. 6.14.1 Affymetrix Company Information
  81. 6.14.2 Affymetrix Business Overview
  82. 6.14.3 Affymetrix Labeled Nucleotides Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Affymetrix Labeled Nucleotides Product Portfolio
  84. 6.14.5 Affymetrix Recent Developments
7 North America by Country
  1. 7.1 North America Labeled Nucleotides Sales by Country
  2. 7.1.1 North America Labeled Nucleotides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Labeled Nucleotides Sales by Country (2021-2026)
  4. 7.1.3 North America Labeled Nucleotides Sales Forecast by Country (2027-2032)
  5. 7.2 North America Labeled Nucleotides Market Size by Country
  6. 7.2.1 North America Labeled Nucleotides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Labeled Nucleotides Market Size by Country (2021-2026)
  8. 7.2.3 North America Labeled Nucleotides Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Labeled Nucleotides Sales by Country
  2. 8.1.1 Europe Labeled Nucleotides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Labeled Nucleotides Sales by Country (2021-2026)
  4. 8.1.3 Europe Labeled Nucleotides Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Labeled Nucleotides Market Size by Country
  6. 8.2.1 Europe Labeled Nucleotides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Labeled Nucleotides Market Size by Country (2021-2026)
  8. 8.2.3 Europe Labeled Nucleotides Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Labeled Nucleotides Sales by Country
  2. 9.1.1 Asia-Pacific Labeled Nucleotides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Labeled Nucleotides Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Labeled Nucleotides Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Labeled Nucleotides Market Size by Country
  6. 9.2.1 Asia-Pacific Labeled Nucleotides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Labeled Nucleotides Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Labeled Nucleotides Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Labeled Nucleotides Sales by Country
  2. 10.1.1 South America Labeled Nucleotides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Labeled Nucleotides Sales by Country (2021-2026)
  4. 10.1.3 South America Labeled Nucleotides Sales Forecast by Country (2027-2032)
  5. 10.2 South America Labeled Nucleotides Market Size by Country
  6. 10.2.1 South America Labeled Nucleotides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Labeled Nucleotides Market Size by Country (2021-2026)
  8. 10.2.3 South America Labeled Nucleotides Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Labeled Nucleotides Sales by Country
  2. 11.1.1 Middle East and Africa Labeled Nucleotides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Labeled Nucleotides Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Labeled Nucleotides Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Labeled Nucleotides Market Size by Country
  6. 11.2.1 Middle East and Africa Labeled Nucleotides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Labeled Nucleotides Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Labeled Nucleotides Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Labeled Nucleotides Value Chain Analysis
  2. 12.1.1 Labeled Nucleotides Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Labeled Nucleotides Production Mode & Process
  7. 12.2 Labeled Nucleotides Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Labeled Nucleotides Distributors
  10. 12.2.3 Labeled Nucleotides Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst